Qualcomm vs Arm jury verdict is imminent — trade the verdict-day volatility, not a side

Verdict: The ARM-QCOM verdict trade is well-aimed but unproven — wait for the trigger, not the headline

The idea's core logic is sound: per the Reuters report of October 9, 2026, Qualcomm and Arm await a jury verdict, and a licensing ruling should reprice at least one of these two income statements materially — ARM's operating margin jumped about 14 points to 29.5% in its quarter ended March 31, 2026, while QCOM's most recent quarter showed revenue down 6.2% to $9.9B, free cash flow down 74% to $495M, and net margin down nearly 50 points to 20.1%. The strongest point against is that the strategy's own completed 24-month backtest delivered 8 trades at a 50% win rate and a -0.27% total return with an 11.9% maximum drawdown, and no robust parameter setup was established because the ARM daily series could not be loaded — so the edge rests on the post-verdict drift claim, not on demonstrated results. The filed ownership record for the period ended September 30, 2026 also shows net open-market insider selling at QCOM of roughly $11.3M across 61 holders (provisional coverage), a dated but live bearish overhang. The verdict itself: wait — no position until the entry conditions complete (two of three are already met, with the MACD crossover at zero distance) or the setup resets. What would flip it: a confirmed MACD crossover at the $177.71 support with an announced verdict date would make this actionable at the 2.39% risk / 4.78% target geometry. Conviction scores below reflect weak backtest evidence and a soft QCOM fundamental trend, offset by a genuinely binary event catalyst and near-complete entry readiness.

Trade now: ARM/QCOM verdict play — one rule short of live

**Where the setup stands.** The idea argues you shouldn't guess the jury verdict — you own the volatility and trade the direction the market confirms afterward, since IP-verdict losers tend to keep sliding as analysts cut estimates. The strategy is built for that confirmation: it goes long on strength-with-pullback conditions rather than pre-verdict guessing. On the live QCOM chart, two of three entry conditions are already met — the ADX reads 26.3, above its 25 threshold, and price at $177.72 sits about 0.8% below the 20-period EMA at $179.19. The remaining condition, the MACD line crossing below its signal line, is effectively at the trigger: the reading sits at the crossover point with zero distance remaining. One clean down-tick confirms it. ARM's intraday feed has no usable candles this session, so its side of the pair cannot be read live right now. **Risk framing if triggered.** The strategy's fixed-risk sizing caps loss per position at 2.39% of equity with a maximum 25% position, against a take-profit at +4.78% — a built-in 2-to-1 reward-to-risk. The nearest support on the live chart is at $177.71, essentially where price trades now, so a break of that level is the immediate watch. The evidence base is a completed 24-month backtest on the ARM leg: 8 trades, a 50% win rate, -0.27% total return, and an 11.9% maximum drawdown — a modest profile, which is exactly why the 2:1 payoff geometry and the post-verdict drift thesis (the higher-conviction leg, per the idea) carry the trade rather than the raw hit rate. One caveat on scope: no robust parameter setup was established because the frozen strategy could not be evaluated for optimization, so the published settings are what you trade. **What "wait" means concretely.** Wait means: no position until the MACD crossover completes alongside the already-met ADX and price-below-EMA conditions. Do not front-run the verdict itself — the strategy's design is to enter on technical confirmation, not the headline. If price reclaims the EMA at $179.19 before the crossover prints, the setup resets and you stand down. If triggered, size to the 2.39% risk rule and let the 4.78% target or the 2.39% stop resolve the position.

Why the bull case still has support

The event mechanics behind this idea are real and immediate. Per the Reuters report from October 9, 2026, Qualcomm and Arm are headed to a jury verdict in their contract-breach feud, and the idea's core claim — that a licensing verdict produces a large, fast repricing because one company's royalty position is directly at stake — fits the situation exactly. For a pair like ARM/QCOM, where roughly $4.9B of ARM's fiscal 2026 revenue (up 22.8% year over year) is intertwined with the licensing economics that QCOM's $44.3B fiscal 2025 revenue base depends on, the magnitude of repricing on a verdict is plausibly outsized relative to an ordinary earnings print. The evidence base is a completed backtest, not just a narrative. Over the evaluated 24-month daily window on the ARM pair, the strategy took 8 trades with a 50% win rate, an overall return of roughly -0.3%, and a maximum drawdown of about 11.9%. The equity curve shows the pattern the thesis depends on: long flat stretches, then sharp multi-percent swings — for example, a move from roughly -4.8% to +11.3% within two monthly checkpoints in the most recent stretch of the window. That is exactly the volatility-harvesting profile the idea describes: own the event window, let the dislocations pay. The fundamentals give the trade two live vessels for a large move. ARM's Q1 (period ended March 31, 2026) showed gross margin of 97.9% and operating margin jumping nearly 14 points quarter over quarter to 29.5% — a business where a licensing ruling moves almost straight to profit. QCOM's most…

Scores

• Conviction score breakdown: 52
• Thesis support: 65
• Trade readiness: 70
• Risk quality: 50
• Backtest evidence: 35
• Fundamentals trend: 40

Watch items

• QCOM — MACD (12,26,9) crossover of signal line
• QCOM — ADX (14)
• QCOM — Price vs EMA (20)
• QCOM — Nearest support level
• QCOM — Insider net open-market activity
• ARM — Operating margin (Q1, ended 2026-03-31)
• QCOM — Free cash flow (Q3, ended 2026-06-28)
• QCOM — RSI (14)